NCT00538226

Brief Summary

This is an open label pilot study to evaluate the efficacy and the safety of the Flowaid device in increasing local circulation in the legs. 15 patients with a diagnosis of Peripheral Vascular Disease will be enrolled in this study. They will recieve tratment with the Flowaid device and monitored continuously by means of Laser Doppler Flowmetry as well as by tcPO2 and Digital Thermography. Subjective data will also be collected.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Oct 2007

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2007

Completed
2 days until next milestone

Study Start

First participant enrolled

October 1, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 2, 2007

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2007

Completed
Last Updated

March 4, 2008

Status Verified

March 1, 2008

First QC Date

September 29, 2007

Last Update Submit

March 3, 2008

Conditions

Interventions

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Give appropriate written informed consent prior to participation in the study
  • Have a current diagnosis of Type I or Type II Diabetes Mellitus
  • Have an Ankle-Arm Index between 0.35 and 0.8 on the study limb
  • Be in reasonable metabolic control, exhibited by HbA1C values of less than12% as observed by serum test results obtained within 3 months prior to the Screening Visit
  • Subject and caregiver must be accessible for, and willing to comply with, the safety procedures and available for the 12 week Follow-Up Period

You may not qualify if:

  • Clinical evidence of gangrene on any part of affected foot
  • Active Charcot's foot on the study limb
  • Scheduled to undergo vascular surgery, angioplasty, or thrombolysis within 30 days from the end of the study
  • Malnourished as evidenced by a pre-albumin of \< 11 mg/dL
  • Pregnancy or lactating
  • History of bleeding disorder
  • Participation in another device study for the treatment of Peripheral Vascular Disease 30 days prior to Screening Visit
  • Vascular procedures performed 30 days prior to Screening Visit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York College of Podiatric Medicine

New York, New York, 10035, United States

Location

MeSH Terms

Conditions

Peripheral Vascular Diseases

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Eileen Chusid, PHD

    New York College of Podiatric Medicine

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
INDIV

Study Record Dates

First Submitted

September 29, 2007

First Posted

October 2, 2007

Study Start

October 1, 2007

Study Completion

November 1, 2007

Last Updated

March 4, 2008

Record last verified: 2008-03

Locations